3/2020

Pearls, Pitfalls, and Conditions that Mimic Mesenteric Ischemia at CT.

Fitzpatrick, L. A., Rivers-Bowerman, M. D., Thipphavong, S., Clarke, S. E., Rowe, J. A., & Costa, A. F. (2020). Pearls, Pitfalls, and Conditions that Mimic Mesenteric Ischemia at CT. RadioGraphics, 40(2), 545-561.

11/2019

The Experiences of Young Adults Living with Metastatic/Advanced Cancer: A Scoping Review

Drake, E. K., & Urquhart, R. (2019). The Experiences of Young Adults Living with Metastatic/Advanced Cancer: A Scoping Review. Journal of Adolescent and Young Adult Oncology.

09/2019

Anesthetic technique and oncological outcomes in urology: A clinical practice review

Lusty, A. J., Hosier, G. W., Koti, M., Chenard, S., Mizubuti, G. B., Jaeger, M., & Siemens, D. R. (2019). Anesthetic technique and oncological outcomes in urology: A clinical practice review. In Urologic Oncology: Seminars and Original Investigations. Elsevier.

08/2019

Naturally Killing the Silent Killer: NK Cell-Based Immunotherapy for Ovarian Cancer

Boudreau, J. E., Nersesian, S., Glazebrook, H., Toulaney, J., & Grantham, S. (2019). Naturally Killing the Silent Killer: NK Cell-Based Immunotherapy for Ovarian Cancer. Frontiers in immunology, 10, 1782.

05/2019

The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry

Azad, T., Ghahremani, M., & Yang, X. (2019). The role of YAP and TAZ in angiogenesis and vascular mimicry. Cells, 8(5), 407.

01/2019

Endothelial Cell–Targeted Deletion of PPARγ Blocks Rosiglitazone-Induced Plasma Volume Expansion and Vascular Remodeling in Adipose Tissue

Akiyama, T. E., Skelhorne-Gross, G. E., Lightbody, E. D., Rubino, R. E., Shi, J. Y., McNamara, L. A., ... & Woods, J. W. (2019). Endothelial Cell–Targeted Deletion of PPARγ Blocks Rosiglitazone-Induced Plasma Volume Expansion and Vascular Remodeling in Adipose Tissue. Journal of Pharmacology and Experimental Therapeutics, 368(3), 514-523.

1/2020

Cardioprotective GLP-1 metabolite prevents ischemic cardiac injury by inhibiting mitochondrial trifunctional protein-α

Siraj, M. A., Mundil, D., ... & Husain, M. (2020). Cardioprotective GLP-1 metabolite prevents ischemic cardiac injury by inhibiting mitochondrial trifunctional protein-α. Journal of Clinical Investigation, 1-13.

10/2019

The Evolutionary Arms Race between Virus and NK Cells: Diversity Enables Population-Level Virus Control

Savoy, S. K., & Boudreau, J. E. (2019). The Evolutionary Arms Race between Virus and NK Cells: Diversity Enables Population-Level Virus Control. Viruses, 11(10), 959.

08/2019

Investigating the STING Pathway to Explain Mechanisms for BCG Failures in Non-Muscle Invasive Bladder Cancer: Prognostic and Therapeutic Implications

Koti, M., Chenard, S., Nersesian, S., Vidotto, T., Morales, A., & Siemens, D. R. (2019). Investigating the STING Pathway to Explain Mechanisms for BCG Failures in Non-Muscle Invasive Bladder Cancer: Prognostic and Therapeutic Implications. Bladder Cancer, 1-10.

07/2019

When“a headache is not just a headache: A qualitative Examination of parent and child experiences of pain after childhood cancer

Tutelman, P. R., Chambers, C. T., Urquhart, R., Fernandez, C. V., Heathcote, L. C., Noel, M., ... & MacLeod, J. (2019). When “a headache is not just a headache”: A qualitative examination of parent and child experiences of pain after childhood cancer. Psycho‐oncology, 28(9), 1901-1909.

04/2019

Beyond cartilage repair: the role of the osteochondral unit in joint health and disease

Lepage, S. I., Robson, N., Gilmore, H., Davis, O., Hooper, A., St. John, S., ... & Koch, T. G. (2019). Beyond cartilage repair: the role of the osteochondral unit in joint health and disease. Tissue Engineering Part B: Reviews, 25(2), 114-125.

10/2018

Blockade of TGFβ signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models

Newsted, D., Banerjee, S., Watt, K., Nersesian, S., Truesdell, P., Blazer, L. L., ... & Craig, A. W. (2019). Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models.  Oncoimmunology, 8(2), e1539613.

12/2019

Ezrin, more than a metastatic detERMinant?

Hoskin, V., Ghaffari, A., & Elliot, B. E. (2019). Ezrin, more than a metastatic detERMinant? Oncotarget 10, 6755-6757.

9/2019

Altered Inheritance: CRISPR and the ethics of genome editing

Baylis, F. (2019).  Altered Inheritance: CRISPR and the ethics of human genome editing. Harvard University Press.

08/2019

Mast cells enhance sterile inflammation in chronic nonbacterial osteomyelitis

Young, S., Sharma, N., Lee, J. H., Chitu, V., Neumeister, V., Sohr, E., ... & Craig, A. W. (2019). Mast cells enhance sterile inflammation in chronic nonbacterial osteomyelitis. Disease models & mechanisms, 12(8), dmm040097.

06/2019

DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes

Vidotto, T., Nersesian, S., Graham, C., Siemens, D. R., & Koti, M. (2019). DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes. Journal for immunotherapy of cancer, 7(1), 148.

03/2019

The tumor immune contexture of prostate cancer

Vitkin, N., Nersesian, S., Siemens, D. R., & Koti, M. (2019). The tumor immune contexture of prostate cancer. Frontiers in immunology, 10.

04/2018

Multi‐omics in high‐grade serous ovarian cancer: Biomarkers from genome to the immunome.

Clifford, C., Vitkin, N., Nersesian, S., Reid‐Schachter, G., Francis, J. A., & Koti, M. (2018). Multi‐omics in high‐grade serous ovarian cancer: Biomarkers from genome to the immunome. American Journal of Reproductive Immunology, 80(2), e12975.